Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...
Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
Agilent Technologies and BaseSolve announce a co-marketing agreement to offer a U.S.-focused integrated solution for NGS workflows. This collaboration provides a streamlined genomics workflow by ...
Researchers explored the cellular cross-talk between endothelial cells and macrophages contributing to peripheral vascular ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Peach buds may be far less dormant than scientists once believed. This study shows that vegetative buds in peach do not ...
Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results